The regulation of glyceride synthesis in isolated white-fat cells. The effects of palmitate and lipolytic agents.
1. 0.5mm-Palmitate stimulated incorporation of [U-(14)C]glucose into glyceride glycerol and fatty acids in normal fat cells in a manner dependent upon the glucose concentration. 2. In the presence of insulin the incorporation of 5mm-glucose into glyceride fatty acids was increased by concentrations of palmitate, adrenaline and 6-N-2'-O-dibutyryladenosine 3':5'-cyclic monophosphate up to 0.5mm, 0.5mum and 0.5mm respectively. Higher concentrations of these agents produced progressive decreases in the rate of glucose incorporation into fatty acids. 3. The effects of palmitate and lipolytic agents upon the measured parameters of glucose utilization were similar, suggesting that the effects of lipolytic agents are mediated through increased concentrations of free fatty acids. 4. In fat cells from 24h-starved rats, maximal stimulation of glucose incorporation into fatty acids was achieved with 0.25mm-palmitate. Higher concentrations of palmitate were inhibitory. In fat cells from 72h-starved rats, palmitate only stimulated glucose incorporation into fatty acids at high concentrations of palmitate (1mm and above). 5. The ability of fat cells to incorporate glucose into glyceride glycerol in the presence of palmitate decreased with increasing periods of starvation. 6. It is suggested that low concentrations of free fatty acids stimulate fatty acid synthesis from glucose by increasing the utilization of ATP and cytoplasmic NADH for esterification of these free fatty acids. When esterification of free fatty acids does not keep pace with their provision, inhibition of fatty acid synthesis occurs. Provision of free fatty acids far in excess of the esterification capacity of the cells leads to uncoupling of oxidative phosphorylation and a secondary stimulation of fatty acid synthesis from glucose.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D002247:Carbon Isotopes; D000242:Cyclic AMP / Q000494:pharmacology*; D004837:Epinephrine / Q000494:pharmacology*; D005227:Fatty Acids / Q000096:biosynthesis / Q000378:metabolism; D005230:Fatty Acids, Nonesterified; D005947:Glucose / Q000378:metabolism; D005989:Glycerides / Q000096:biosynthesis*; D066298:In Vitro Techniques; D008297:Male; D009243:NAD / Q000378:metabolism; D010085:Oxidative Phosphorylation; D010086:Oxidative Phosphorylation Coupling Factors; D010169:Palmitic Acids / Q000494:pharmacology*; D051381:Rats; D014316:Tritium
D002247:Carbon Isotopes; D005227:Fatty Acids; D005230:Fatty Acids, Nonesterified; D005989:Glycerides; D010086:Oxidative Phosphorylation Coupling Factors; D010169:Palmitic Acids; D009243:NAD; D014316:Tritium; D000255:Adenosine Triphosphate; D000242:Cyclic AMP; D005947:Glucose; D004837:Epinephrine